文献速递肿瘤 PET/CT

基线总代谢肿瘤体积联合国际外周T细胞淋巴瘤项目评分可改善PTCL预后分层

Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL).
PubMed 文献 · EJNMMI Res · 2020-09-23

ROC曲线分析得出TMTV理想截断值为228.8 cm3;高TMTV与更差的无进展生存(PFS)和总生存(OS)显著相关。多因素分析显示TMTV和国际外周T细胞淋巴瘤项目评分(IPTCLP)均为PFS和OS的独立预测因素,两者联合可显著改善风险分层。

要点

  • 基线18F-FDG PET/CT的TMTV是PTCL患者PFS和OS的独立预测因素。
  • TMTV理想截断值为228.8 cm3,高TMTV与更差生存显著相关。
  • TMTV联合IPTCLP可显著改善PTCL患者PFS和OS的风险分层。

核心结论

  • TMTV和IPTCLP均为PTCL患者生存结局的独立预测因素。
  • TMTV联合IPTCLP改善了患者风险分层,可能有助于个体化治疗方案。

研究设计与样本

  • 采用41% SUVmax阈值法的半自动软件分割FDG高摄取病灶,计算SUVmax、TMTV和TLG。
  • 以PFS和OS为终点,采用log-rank检验和Cox回归分析评估预后。

主要发现

  • ROC曲线分析显示TMTV理想截断值为228.8 cm3。
  • 随访4-131个月(29.2 ± 28.5个月)期间,高TMTV与更差PFS和OS显著相关。
  • 多因素分析显示TMTV和IPTCLP均为PFS和OS的独立预测因素。
  • TMTV联合IPTCLP可能为PTCL患者PFS和OS提供显著更好的风险亚分层。

关键数值与推荐

  • TMTV理想截断值为228.8 cm3(ROC曲线分析)。
  • 病灶分割采用41% SUVmax阈值法。

临床怎么用

  • 基线18F-FDG PET/CT测量的TMTV可辅助PTCL患者预后评估。
  • TMTV联合IPTCLP可用于改善PTCL患者风险分层,辅助个体化治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to explore the prognostic value of total metabolic tumor volume (TMTV) at baseline 18F-FDG PET/CT in patients diagnosed with peripheral T-cell lymphoma (PTCL). MATERIALS AND METHODS: Eighty-four newly diagnosed PTCL patients who underwent baseline 18F-FDG PET/CT prior to treatment between March 2009 and January 2019 were enrolled in this retrospective study. The FDG-avid lesions in each patient were segmented using semiautomated software to calculate the maximum standardized uptake value (SUVmax), total metabolic tumor volume (TMTV), and total lesion glycolysis (TLG) values using the boundaries of voxels presenting with the 41% SUVmax threshold method. Progression-free survival (PFS) and overall survival (OS) were used as end points to evaluate patient prognosis. The log-rank test and Cox regression analyses were used to evaluate PFS and OS. RESULTS: ROC curve analysis indicated an ideal TMTV cut-off value of 228.8 cm3. During the 4-131 months (29.2 ± 28.5 months) follow-up period, high TMTV was significantly associated with worse PFS and OS. TMTV and the international peripheral T-cell lymphoma project score (IPTCLP) were independent predictors of PFS and OS with multivariate analysis. The combination of TMTV and the IPTCLP may provide significantly better risk substratification in PFS and OS of PTCL patients. CONCLUSIONS: Both TMTV and IPTCLP are independent predictors of PTCL patient survival outcomes. Moreover, the combination of TMTV and IPTCLP improved patient risk stratification and may contribute to personalized therapeutic regimens.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Jiang C, Teng Y, Chen J, et al. Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL). EJNMMI Res. 2020. PMID: 32965554. doi:10.1186/s13550-020-00698-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。